Please login to the form below

Not currently logged in

Q4 results

This page shows the latest Q4 results news and features for those working in and with pharma, biotech and healthcare.

Sanofi to buy mRNA tech partner, Translate Bio, for $3.2bn

Sanofi to buy mRNA tech partner, Translate Bio, for $3.2bn

Sanofi and Translate Bio are currently running two mRNA vaccine clinical trials: a COVID-19 vaccine phase 1/2 study with results expected in Q3 2021 and a mRNA seasonal influenza ... vaccine phase 1 trial with results due in Q4 2021.

Latest news

More from news
Approximately 17 fully matching, plus 29 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Ask the writers: Transitioning from academia to medical writing
Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
Strategic launch planning: familiar framework, new mindset
By James Aird...
How to embrace behavioural science principles in healthcare MR...